UK approves Pfizer/BioNTech Covid-19 vaccine for emergency use next week
London; 02 Dec 2020 (UMMN): UK has become the first western country to license Pfizer/BioNTech Covid-19 vaccine for emergency use from next week for those most at risk, opening the way for mass immunisation.
According to The Guardian, the UK has bought 40m doses of the vaccine, which has been shown to have 95% efficacy in its final trials.